Exploring Time Off Treatment with a BCL-2 Inhibitor ~ Thursday, Nov 7th
top of page
News & Events
Boston ONS supports oncology programs and is now offering event management packages to best suit your program needs. Check it out!
Search
Click here to learn more and register!
Oct 80 min read
6 views0 comments
Oct 81 min read
The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3
Click here to learn more and register!
5 views0 comments
Oct 81 min read
Unlocking the Potential for a Bispecific Antibody in 3L+ DLBCL and 3L+FL ~ Wednesday, October 23rd
Click here to register and learn more! Presented by: Tara Graff, DO Mission Blood + Cancer, Des Moines, Iowa
14 views0 comments
Oct 81 min read
Combined Power to Change the Game: RYBREVANT® + LAZCLUZE™ in First-Line Treatment of EGFR+* Locally Advanced or mNSCLC ~ Thursday, 10/24/24
Click here to register and learn more! Presented by: Mark Socinski, MD Executive Medical Director AdventHealth Cancer Institute, Orlando,...
4 views0 comments
Oct 41 min read
A Step Forward - Initiating VENCLEXTA Treatment in Patients with CLL - October 22nd @ 5:30pm
Click here to learn more and register!
5 views0 comments
Sep 291 min read
Diffuse Large B Cell Lymphoma Update ~ LIVE ~ October 22nd, 6-8pm
Join us on Tuesday, October 22nd, from 6-8pm at Joe's On Newbury for a wonderful overview of Diffuse Large B Cell Lymphoma. Presented by...
11 views0 comments
Aug 251 min read
NEW EVENT! Live presentation on the latest data for Libtayo
REGISTER Check out this upcoming event! Hosted by Regeneron Register today via Boston ONS. More details shared through registration.
27 views0 comments
Jul 231 min read
Understanding AYVAKIT: a treatment option for adults with ISM and AdvSM ~ August 7th, 2024
Presented (on behalf of Blueprint Medicines) by: James McCloskey, MD Chief, Division of Leukemia John Theurer Cancer Center Wednesday,...
40 views0 comments